Form 4 Tracker
Apogee Therapeutics, Inc.
APGE

27 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jul 1, 2026Jul 1 9:00 PMCARL DAMBKOWSKI
Proposed Sale
16,500$132.73$2.2M

View →

Jun 22, 2026Jun 25 12:01 AMCarl DambkowskiChief Medical Officer
Sale
26,400$132.60$3.5M179,248(D)

View →

Jun 22, 2026Jun 25 12:00 AMMichael Thomas HendersonDirector, Chief Executive Officer
Sale
80,000$132.54$10.6M1,015,987(D)

View →

Jun 22, 2026Jun 22 8:48 PMCARL DAMBKOWSKI
Proposed Sale
15,400$90.38$1.4M

View →

Jun 22, 2026Jun 22 2:40 PMHENDERSON MICHAEL THOMAS
Proposed Sale
80,000$132.54$10.6M

View →

Jun 10, 2026Jun 12 9:05 PMMichael Thomas HendersonDirector, Chief Executive Officer
Sale
20,000$83.38$1.7M1,095,987(D)

View →

Jun 3, 2026Jun 6 12:00 AMCarl DambkowskiChief Medical Officer
Sale
5,500$78.71$432.9K205,648(D)

View →

May 13, 2026May 16 12:00 AMMichael Thomas HendersonDirector, Chief Executive Officer
Sale
20,000$82.09$1.6M1,115,987(D)

View →

May 13, 2026May 13 2:34 PMHENDERSON MICHAEL THOMAS
Proposed Sale
60,000$82.47$4.9M

View →

May 6, 2026May 9 12:00 AMCarl DambkowskiChief Medical Officer
Sale
5,500$84.14$462.8K207,023(D)

View →

May 6, 2026May 6 8:25 PMCARL DAMBKOWSKI
Proposed Sale
22,000$83.29$1.8M

View →

May 1, 2026May 5 12:00 AMJane HendersonChief Financial Officer
Sale
2,000$82.04$164.1K173,371(D)

View →

May 1, 2026May 1 8:45 PMJANE HENDERSON
Proposed Sale
2,000$82.89$165.8K

View →

Apr 16, 2026Apr 18 12:00 AMJane HendersonChief Financial Officer
Sale
2,000$90.00$180.0K175,371(D)

View →

Apr 8, 2026Apr 11 12:00 AMMichael Thomas HendersonDirector, Chief Executive Officer
Sale
20,000$82.58$1.7M1,132,987(D)

View →

Apr 1, 2026Apr 4 12:00 AMCarl DambkowskiChief Medical Officer
Sale
5,500$84.84$466.6K208,398(D)

View →

Apr 1, 2026Apr 4 12:00 AMJane HendersonChief Financial Officer
Sale
2,000$85.01$170.0K177,371(D)

View →

Mar 25, 2026Mar 28 12:00 AMJane HendersonChief Financial Officer
Sale
2,000$85.00$170.0K179,371(D)

View →

Mar 25, 2026Mar 25 8:24 PMJANE HENDERSON
Proposed Sale
6,000$73.00$438.0K

View →

Mar 11, 2026Mar 14 12:00 AMMichael Thomas HendersonDirector, Chief Executive Officer
Sale
20,000$74.78$1.5M1,152,987(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 9, 2026Jun 12 12:04 AMFairmount Funds Management LLCDirector
Grant/Award
7,657$85.007,657(I)

View →

Jun 9, 2026Jun 12 12:03 AMNimish P ShahDirector
Grant/Award
7,657$85.007,657(D)

View →

Jun 9, 2026Jun 12 12:03 AMMark C. MckennaDirector
Grant/Award
7,657$85.007,657(D)

View →

Jun 9, 2026Jun 12 12:02 AMWilliam A Jones JRDirector
Grant/Award
7,657$85.007,657(D)

View →

Jun 9, 2026Jun 12 12:01 AMJennifer A. FoxDirector
Grant/Award
7,657$85.007,657(D)

View →

Jun 9, 2026Jun 12 12:00 AMLisa BollingerDirector
Grant/Award
7,657$85.007,657(D)

View →

Jun 3, 2026Jun 6 12:00 AMCarl DambkowskiChief Medical Officer
Option Exercise
4,125$22.86118,915(D)

View →

May 6, 2026May 9 12:00 AMCarl DambkowskiChief Medical Officer
Option Exercise
4,125$22.86123,040(D)

View →

Apr 16, 2026Apr 20 8:05 PMMichael Thomas HendersonDirector, Chief Executive Officer
Option Exercise
3,000$22.86387,012(D)

View →

Apr 1, 2026Apr 4 12:00 AMCarl DambkowskiChief Medical Officer
Option Exercise
4,125$22.86127,165(D)

View →

Mar 4, 2026Mar 7 1:00 AMCarl DambkowskiChief Medical Officer
Option Exercise
4,125$22.86131,290(D)

View →

Feb 4, 2026Feb 5 1:02 AMCarl DambkowskiChief Medical Officer
Option Exercise
4,125$22.86135,415(D)

View →